Real-world evidence research in metastatic colorectal cancer: raising awareness of the need for patient contributions.
Future Oncol
; 19(26): 1809-1821, 2023 Aug.
Article
en En
| MEDLINE
| ID: mdl-37439564
Real-world evidence (RWE) research provides information that is essential to improving medical treatment. When it comes to metastatic colorectal cancer cancer that has spread to other parts of the body only a few RWE studies have been conducted. RWE studies, such as the ongoing PROMETCO study in patients with metastatic colorectal cancer, differ from clinical trials in that they include a wider range of people with fewer restrictions on type of treatments received. They can also place more attention to the patients' own opinions. By joining RWE studies, patients are likely to become more interested in their disease and take a more active role in their treatment. In the end, this can help to improve their quality of life and possibly improve the outcomes of their treatment. Doctors need to work in partnership with patients to increase participation in RWE studies.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Pacientes
/
Neoplasias Colorrectales
Límite:
Humans
Idioma:
En
Revista:
Future Oncol
Año:
2023
Tipo del documento:
Article
País de afiliación:
Bélgica